Jan 17 (Reuters) - ISOFOL MEDICAL AB:
* SUCCESSFUL END-OF-PHASE 2 MEETING WITH FDA AND PHASE 3 PROGRAM FOR MODUFOLIN® AGREED
* ‍HAS HAD SUCCESSFUL REGULATORY MEETING WITH US FDA, IMPORTANT MILESTONE IN REGULATORY PROCESS​
* ‍PHASE III STUDY, ISO-CC-007, IS EXPECTED TO BE COMPLETED BY 2020/2021​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)
 